Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NVCR - FDA OKs Novocure's TTF for mesothelioma under HDE status; shares up 4% after hours


NVCR - FDA OKs Novocure's TTF for mesothelioma under HDE status; shares up 4% after hours

  • The FDA approves Novocure's (NASDAQ:NVCR) NovoTTF-100L System, combined with Eli Lilly's (NYSE:LLY) Alimta (pemetrexed) and platinum-based chemo, for the first-line treatment of locally advanced or metastatic malignant pleural mesothelioma (MPM).
  • More news on: NovoCure Limited, Eli Lilly and Company, Healthcare stocks news, Stocks on the move,
  • Read more ...
Stock Information

Company Name: NovoCure Limited
Stock Symbol: NVCR
Market: NASDAQ
Website: novocure.com

Menu

NVCR NVCR Quote NVCR Short NVCR News NVCR Articles NVCR Message Board
Get NVCR Alerts

News, Short Squeeze, Breakout and More Instantly...